Androgenetic alopecia
Therapeutic area
Dermatology
Rare disease
No
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- Androgenetic alopecia
- Therapeutic area
- Dermatology
- androgenetic alopecia
- male pattern baldness
- All therapeutic areas
- Dermatology
- Severity
- Unknown
- MONDO ID
- MONDO:0005339
- Parent condition
- MONDO:0021208
Related records
Broader conditions (9)
- Alopecia
- Disease
- Disease by body system or component
- Disorder of pilosebaceous unit
- Endocrine alopecia
- Hair anomaly
- Human disease
- Integumentary system disorder
- Skin appendage disorder
Narrower conditions (4)
- Alopecia, androgenetic, 1
- Alopecia, androgenetic, 2
- Alopecia, androgenetic, 3
- Baldness, male pattern
Trials (190)
- 1470nm Laser for the Treatment of Androgenetic Alopecia and Scarring Alopecia
- 24 Week Clinical Trial to Evaluate Safety and Effectiveness of a Hair Growth System to Treat Male and Female Baldness
- A Clinical Trial to Assess Pharmacokinetic/Pharmacodynamic Profiles and Safety of IVL3001
- A Novel Approach to Treating Androgenetic Alopecia in Females With Low Level Laser Therapy
- A Phase 1 Study of TDM-105795 Topical Solution in Male Subjects With Androgenetic Alopecia (AGA)
- A Phase 2 Study to Evaluate the Safety and Efficacy of CB-03-01 Solution, a Comparator Solution and Vehicle Solution in Males With Androgenetic Alopecia
- A Phase 2 Study to Evaluate the Safety and Efficacy of CKD-498 in Female Patients With Androgenetic Alopecia
- A Phase 2a Trial of FOL-005 Topical Formulations to Investigate Hair Growth Potential and Safety in Healthy Male Volunteers
- A Phase 3 Study to Evaluate the Safety and Efficacy of CKD-843 in Male Patients With Androgenetic Alopecia
- A Randomized, Double-blind Clinical Trial to Evaluate the Safety and Efficacy of the X5 HairLaser for the Treatment of Androgenetic Alopecia in Males
- A Safety and Efficacy Study of Bimatoprost in Men With Androgenic Alopecia (AGA)
- A Safety and Efficacy Study of PDFE-2304 Topical Solution for the Treatment of Androgenic Alopecia.
- A Split-Scalp Study Evaluating the Efficacy and Safety of Fractional Laser Therapy With and Without Exosomes in the Treatment of Androgenetic Alopecia
- A Study Evaluating the Efficacy and Safety of SM04554 Topical Solution in Male Subjects With Androgenetic Alopecia
- A Study Evaluating the Hair Regrowth Efficacy and Safety of ALRV5XR in Female Subjects With Hair Loss
- A Study Evaluating the Hair Regrowth Efficacy and Safety of ALRV5XR in Male Subjects With Hair Loss
- A Study in Male and Female Subjects With Androgenetic Alopecia Treated With ATI-50002 Topical Solution
- A Study of SM04554 Applied Topically to the Scalp of Male Subjects With Androgenetic Alopecia Analyzed by Biopsy of the Scalp Prior To and Post Dosing
- A Study of TDM-105795 in Male Subjects With Androgenetic Alopecia (AGA)
- A Study of the Safety, Tolerability, and Efficacy of Topical SM04554 Solution in Male Subjects With Androgenetic Alopecia (AGA)
Approved drugs (2)
- Finasteride
- Minoxidil
Drugs in development (10)
- Bimatoprost Phase 2
- Cetirizine Phase 2
- Clascoterone Phase 3
- Dalosirvat Phase 2
- Dutasteride Phase 3
- Edoxaban tosylate Phase 2
- Ifidancitinib Phase 2
- Incobotulinumtoxina Phase 2
- Onabotulinumtoxina Phase 2
- Valproic acid Phase 2